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B I O C H E M I S T R Y
Polysaccharide length affects mycobacterial cell shape 
and antibiotic susceptibility
Alexander M. Justen1,2*, Heather L. Hodges3, Lili M. Kim2, Patric W. Sadecki3, Sara Porfirio4, 
Eveline Ultee5, Ian Black4, Grace S. Chung2, Ariane Briegel5, Parastoo Azadi4, Laura L. Kiessling1,2,3,6†
Bacteria control the length of their polysaccharides, which can control cell viability, physiology, virulence, and 
immune evasion. Polysaccharide chain length affects immunomodulation, but its impact on bacterial physiology 
and antibiotic susceptibility was unclear. We probed the consequences of truncating the mycobacterial galactan, 
an essential linear polysaccharide of about 30 residues. Galactan covalently bridges cell envelope layers, with the 
outermost cell wall linkage point occurring at residue 12. Reducing galactan chain length by approximately half 
compromises fitness, alters cell morphology, and increases the potency of hydrophobic antibiotics. Systematic 
variation of the galactan chain length revealed that it determines periplasm size. Thus, glycan chain length can 
directly affect cellular physiology and antibiotic activity, and mycobacterial glycans, not proteins, regulate 
periplasm size.
INTRODUCTION
Bacteria generate cell surface polysaccharides of controlled size. 
Biosynthesis of these glycans occurs through processes that regulate 
chain length (1), indicating that polysaccharide length is linked to 
function. The one known function for saccharide chain length is to 
influence the potency of immunomodulatory glycans. For instance, 
in Salmonella enterica, O-antigens of >100 repeat units serve as 
physical barriers that facilitate bacterial evasion of complement- 
mediated killing (2). Alternatively, in mycobacteria, the cell surface 
glycoconjugate lipoarabinomannan (LAM) affects host immuno-
modulation (3). When arabinan branching is disrupted, the mannan 
core of LAM is more efficiently recognized by macrophages as foreign; 
consequently, the host mounts a proinflammatory response (4). Beyond 
immunomodulatory glycans, however, the effects of polysaccharide 
chain length on bacterial physiology and survival are not apparent.
An essential polysaccharide whose length is controlled is the myco-
bacterial galactan. The galactan’s only known function is to cova-
lently link the peptidoglycan (PG) and arabinan (5). The mycobacterial 
galactan anchors to the PG through the galactan reducing end, and 
genetic perturbation studies indicate that the 8th, 10th, and 12th , 
d-galactofuranose (Galf) residues of the polysaccharide act as branch 
points for the arabinan (Fig. 1A) (6). The galactan consists of ap-
proximately 30 Galf residues such that it extends far beyond the 12 
residues needed for branching (6–9). The “extra” length of this glycan 
appears to be disconnected from immune regulation because the 
galactan is positioned within the mycobacterial periplasm and not 
on the cell surface (10, 11). To assess the importance of galactan 
length, we tested the consequences of its truncation.
To engineer galactan chain length, we focused on galactofuranosyl 
transferase 2 (GlfT2), the biosynthetic polymerase responsible for 
galactan elongation (Fig. 1B) (12). This GT2-family glycosyltransferase 
acts on a Galf-primed precursor in the cytoplasm and appears to con-
trol galactan length. Recombinant Mycobacterium tuberculosis GlfT2 
can process a synthetic acceptor to yield glycans of physiologically 
relevant chain lengths (12). The number of saccharide residues in 
the glycan product was altered by introducing single-point sub-
stitutions into the tri-aspartate (DDD) metal ion binding motif in-
volved in binding of the sugar donor uridine diphosphate (UDP)–
Galf) (13, 14). We hypothesized that replacing wild-type (WT) 
GlfT2 in Mycobacterium smegmatis with a variant could afford cells 
with a truncated galactan, and that these mutant cells would reveal 
the contributions of galactan chain length to bacterial physiology.
RESULTS
To generate mutants with shorter galactan, we characterized M. smeg 
GlfT2 (gene ID: Msmeg_6403). Chain elongation experiments with re-
combinant WT M. smeg GlfT2 afforded polysaccharides of similar 
length as those generated by M. tuberculosis GlfT2 (Fig. 1, B and C). We 
generated D267E and D267A variants of M. smeg GlfT2, as these variants 
have substitutions at the metal ion binding motif; therefore, they should 
bind UDP-Galf less well and afford shorter galactan chains (fig. S1) (14). 
In a chain elongation assay, D267A GlfT2 was only able to transfer a few 
Galf residues to acceptor, but D267E GlfT2 afforded products about half 
the length of those obtained using WT GlfT2 (Fig. 1C). We therefore 
introduced glfT2 point mutants to an M. smeg strain lacking endo genous 
glfT2. Using a modified approach to mycobacterial recombineering (15), 
we deleted glfT2 at its endo genous site while providing complemen-
tation through exogenous expression of Flag-glfT2 from an integration 
proficient plasmid (16). Expression of D267A Flag-glfT2 did not 
complement, but the D267E Flag-glfT2 construct did (fig. S2).
To determine whether the galactan length had been altered in cells, 
we analyzed the monosaccharide composition of WT, Flag-glfT2 
complemented (WTcomp), and D267E Flag-glfT2 complemented 
(D267Ecomp) cells (fig. S3) (17). Because each galactan chain contains 
one rhamnose (Rha) residue, the ratio of galactose to rhamnose 
(Gal:Rha) is a surrogate for average galactan chain length. Applying 
this analysis revealed that D267Ecomp cells generate galactan chains 
approximately twofold shorter than WT cells (Table 1 and fig. S3). 
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The arabinosylation of the D267Ecomp strain was within 5% of the 
WTcomp strain, implying that the galactan chain in the mutant 
undergoes arabinan formation. Next, we determined whether any 
other saccharide units or lipids in the D267Ecomp cell envelope had 
changed. No change in the identity of covalently associated lipids or 
the relative amount of galactan appended to the cell wall was detected. Any 
changes in composition of free lipids and lipoarabinomannan (LAM) 
were minimal (fig. S3). Thus, the major perturbation of D267Ecomp cells 
is a truncated galactan.
A growth defect of D267Ecomp cells was readily apparent, as their 
doubling time was approximately 1.5-fold slower than that of WT 
(Fig. 2A). Extracellular glycans can influence a cell’s ability to with-
stand osmotic pressure (18, 19); therefore, we tested whether hyper-
osmotic stress would further exacerbate this defect. We evaluated 
osmolyte tolerance for WT, WTcomp, and D267Ecomp cells and found 
that the mutant strain was much less resistant to hyperosmotic 
stress (fig. S4). When exposed to high salt concentration (~500 mM 
sodium chloride), the growth rate was severely restricted.
We profiled cells cultured in hyperosmotic medium containing 
250 mM sodium chloride (about 15-fold higher than standard con-
ditions) using RNA sequencing (RNA-seq). Data from the surviving 
population indicate that the genes associated with nutrient acquisition 
(Fig. 2B and table S1) and proteostasis are up-regulated. Increasing 
the levels of proteins that mediate proteostasis can mitigate osmotic 
stress (20). The mutant cells strongly up-regulate these pathways, 
thereby underscoring their high sensitivity.
M. smeg mutants with defects in cell wall biosynthesis are hyper-
sensitive to select antibiotics (7, 21). We, therefore, assessed the 
viability of the D267Ecomp strain after antibiotic exposure (Fig. 2C). 
We reasoned that loss of proper glycan chain length could result 
in either an alteration of cell envelope permeability to facilitate 
antibiotic uptake or an increase in the susceptibility of the relevant 
biosynthetic pathway to inhibition. Consequently, we tested a panel of 
antibiotics with diverse hydrophobicities and mechanisms of action. 
D267Ecomp cells were more susceptible than WT to numerous antibiotics 
(fig. S5); however, those antibiotics did not share a related mechanism 
of action. For example, no potency increases were observed for anti-
biotics targeting the cell envelope. In addition, hydrophilic antibiotics, 
such as streptomycin or meropenem, exhibited no change in activity. 
These findings align with results from our lipid analysis experiments 
indicating that the mutant has an intact mycolic acid–rich outer mem-
brane, as this layer is likely the major barrier for hydrophilic antibiotics. 
In contrast, hydrophobic antibiotics were more effective on the mutant. 
Specifically, hydrophobic agents with unrelated mechanisms of ac-
tion, such as rifampicin and novobiocin, were more potent (fig. S5).
Deletion of nonessential genes involved in cell wall polysaccharide 
biosynthesis can alter bacterial cell shape and cell envelope architec-
ture (19, 22). Consequently, we evaluated cell shape of D267Ecomp 
cells using microscopy. Using a membrane stain to illuminate the 
cell outline, we found that relative cell length had decreased (fig. S6). 
To better observe any defects in cell growth and division, we next 
conducted time-lapse microscopy in a microfluidics chamber 
(movies S1 to S6). M. smeg cells are normally long, thin rods; how-
ever, defects in cell envelope biosynthesis can result in “blebbing,” a 
phenotype characterized by the appearance of circular protrusions 
(Fig. 3A). Analysis of time-lapse microscopy revealed that D267Ecomp 
cells undergo blebbing, and numerous instances of cell rupture were 
detected during division. These phenotypes also have been observed 
with mutants of PG biosynthesis, in which atomic force microscopy 
indicated a substantial decrease in cell wall rigidity (23). These data 
underscore the underappreciated contributions the galactan makes 
to cell structure and rigidity.
The effect of the galactan on cell length and rigidity prompted us 
to examine the architecture of the mutant cell envelope. We used 
transmission electron microscopy (TEM) to visualize WT, WTcomp, 
and D267Ecomp cells. The morphology of multiple D267Ecomp cells 
was indicative of blebbing, consistent with our previous observa-
tions (fig. S6). In the mutant, the periplasm, the region where the 
galactan resides, had contracted (Fig. 3B and fig. S6). On average, 
the thickness of the periplasm of D267Ecomp cells was decreased by 
about 30% (Fig. 3C). To better understand the relationship between 
galactan chain length and cell shape, we generated a set of strains 
whose galactan length varied systematically.
Table 1. Monosaccharide composition analysis of cell envelope 
isolated from WT, WTcomp, and D267Ecomp strains. Ratios are the 
average of three biological replicates 
Ara Gal Rha
WT 64 34 1
WTcomp 59 33 1





























































































































Fig. 1. The galactan and the mycobacterial cell envelope. (A) Schematic depiction 
of the envelope of mycobacteria highlighting the mAGP (mycolyl-arabinogalactan- 
peptidoglycan). The glycans are depicted with the standard nomenclature. 
(B) Galactofuranosyl transferase 2 (GlfT2) extends the galactan to its final length. 
Polymerase activity can be probed in vitro using purified protein, synthetic accep-
tor, and sugar donor. (C) Overlayed matrix-assisted laser desorption/ionization–
time-of-flight (MALDI-TOF) spectra produced by GlfT2 metal ion binding variants. 
Number of Galf residues added to acceptor noted above major product peaks.
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Orthologs of GlfT2 have been identified across the Corynebacterineae 
suborder, and previous investigations indicate that orthologous 
GlfT2s have distinct chain length control (24). We introduced the 
glfT2 genes from either Nocardia brasiliensis (Nbras) or Corynebacterium 
diphtheriae (Cdiph) into our glfT2- deficient M. smeg strain. These or-
thologs complemented growth, and in both Cdiphcomp and Nbrascomp 
strains, the galactan chain length was shorter than that of WT (Fig. 3D 
and fig. S7). The frequency of cell blebbing increases as galactan size 
decreases (fig. S6). We therefore imaged these cells using TEM. The 
results showed that periplasm thickness and galactan chain length 
were correlated (Fig. 3, E and F).
To validate the relationship between galactan chain length and 
periplasm size, we examined these strains using cryo-TEM. Because 
chemical fixation, dehydration, or embedding of samples was not 
required, the cells can be imaged in a near-native state. We visualized 
WT, WTcomp, Cdiphcomp, Nbrascomp, and D267Ecomp strains using 
cryo-TEM and measured average periplasm size for each strain 
(Fig. 4A). The data from this analysis recapitulated the trend seen 
using conventional TEM (Fig.  4,  B  and  C). Among these strains, 
galactan chain length correlated directly with periplasm size, with 
an average contribution of 3.2 Å per Galf residue.
DISCUSSION
Many polysaccharides, including the galactan, are assembled in the 
cytoplasm and then transported into the extracellular space; there-
fore, export and chain length control are tightly coupled (25, 26). 
Our ability to isolate a mycobacterial strain with a truncated galac-
tan indicates that there is flexibility in chain length required for 
transport. This flexibility would endow mycobacteria the freedom 
to modulate chain length in response to environmental stimuli without 
creating a need to modify other cellular machinery. M. smeg strains 
with truncated arabinan increase the length of their galactan, per-
haps as a compensatory mechanism (7).
Our finding that galactan truncation results in hypersensitivity 
to hydrophobic antibiotics underscores an important role for bacterial 
polysaccharides. In M. smeg, deletion mutants lacking arabinofu-
ranosyl transferases are similarly sensitized to hydrophobic anti-
biotics (7). Still, the role of the glycan in these arabinan-deficient 
strains was difficult to address as these strains lack the ability to 
generate some glycan linkages altogether and harbor outer mem-
brane defects. Antibiotic hypersensitivity of D267Ecomp cells indi-
cates that changes in glycan chain length alone increase antibiotic 
permeability. For both Gram-positive and Gram-negative bacteria, 
cell surface polysaccharides appear to form a barrier against hydro-
phobic antibiotics (27, 28). This role for glycans is apparent in the 
combinations of tuberculosis frontline antibiotics that act synergis-
tically. Ethambutol, an inhibitor of arabinan biosynthesis, synergizes 
with the hydrophobic drug rifampicin, whereas isoniazid, an in-
hibitor of mycolic acid biosynthesis, does not (29). Together, these 
data demonstrate the role cell envelope polysaccharides play in de-
termining permeability and illustrate chain length as an important 
determinant of polysaccharide biological function.
We characterized features of the cell envelope of the D267Ecomp 
strain and found that galactan chain length is the major alteration. 
Some minor changes were also observed. An unidentified lipid spe-
cies appeared to increase, and we surmise that up-regulation of this 
lipid helps compensate for galactan truncation. In addition, LAM 
produced by the D267Ecomp strain migrates as a higher molecular 
weight species during SDS–polyacrylamide gel electrophoresis 
(PAGE) analysis. This finding is intriguing because LAM appeared 
different, yet the immediate LAM precursor lipomannan was un-
changed. This result implies that between these strains, changes 
occurred to either LAM arabinosylation or LAM tailoring (30). 
Both of these processes occur within the periplasm, suggesting that 
LAM biosynthesis is affected by reduction of periplasm size. Emerg-
ing work, particularly the identification of a galactan hydrolase 
(31), also indicates that a dynamic remodeling of the cell envelope 
happens within the periplasm. Thus, exploring important biological 
periplasmic processes, including LAM biosynthesis as well as PG 
assembly and remodeling, could provide insight into cell envelope 
assembly.
The importance of the periplasm in Gram-negative bacteria is 
well established; this compartment has roles in processes that in-
clude nutrient acquisition, protein secretion, and cell wall assembly 
(32). Still, the consensus that mycobacteria have a periplasm has 
only emerged in the past decade (10, 11) and comparatively little is 
known regarding its function. Gram-negative and mycobacterial 
periplasm biology highlights important similarities. In Gram-negative 
bacteria, the periplasm size is dictated by the protein Lpp such that 
one end of the protein is covalently linked to the PG, while the other 
contains a lipid anchor to the outer membrane (33). In contrast, 
in mycobacteria, a glycan functions as the bridge between the PG 
and the outer membrane, and our data indicate that the galactan 
dictates periplasm size. Changing the dimensions of the periplasm 
has consequences. For example, in S. enterica, increasing or decreasing 
periplasm size impairs motility and changes cell morphology (33). 
Growth (7H9)A
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Fig. 2. Impact of galactan truncation on fitness. (A) Growth rate monitored in 
standard 7H9 medium. (B) RNA-seq data highlighting genes substantially up-regulated 
in D267Ecomp cells during hyperosmotic challenge. (C) Changes in the minimum 
inhibitory concentrations (MICs) of hydrophobic drugs (green), like novobiocin, 
versus hydrophilic drugs (black), like streptomycin. Antibiotic targets are listed.
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For mycobacteria, decreasing periplasm size appears to disrupt nor-
mal nutrient uptake, as D267Ecomp cells subjected to hyperosmotic 
challenge strongly up-regulate nutrient acquisition machinery. Last, 
in Escherichia coli, the Rcs system detects periplasm stress, in part 
by the protein RcsF (34). In M. smeg, there are two proteins with 
sequence similarity to RcsF (table S1 and fig. S8). The transcript for 
one (Msmeg_0699) is among the most highly up-regulated in 
D267Ecomp cells during normal growth and hyperosmotic challenge. 
This finding suggests that periplasm size is a cellular attribute that 
mycobacteria maintain and monitor.
Fig. 3. Galactan chain length affects cell shape and periplasm size. (A) Time-lapse microscopy images of M. smegmatis glfT2 mutants. Galactan truncation led to bleb-
bing morphology (arrows) and, in multiple instances, cell rupture during division. (B) TEM of M. smegmatis glfT2 mutants highlighting the periplasm (arrows). (C) Galactan 
truncation decreases periplasm size in M. smegmatis (P < 0.0001). (D) Introduction of glfT2 orthologs affords access to strains with altered galactan chain length. (E) TEM 
images were used to quantify periplasm thickness across ortholog complemented strains. (F) Periplasm size and galactan chain length correlate linearly.
Fig. 4. Native-state imaging of glfT2 engineered M. smeg. (A) Cryo-TEM micrographs of WT, WTcomp, and D267Ecomp strains. Boundaries of periplasm are highlighted 
with red lines (left). (B) Quantification of periplasm size. (C) Cryo-TEM data analysis correlates with galactan chain length and periplasm size.
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Polysaccharides decorate the surface of all cells. The length of 
the glycan chains is controlled, but how chain length affects bacterial 
physiology has been unclear. Before this study, the only known role 
of chain length had been to influence immunomodulatory proper-
ties (1). We found that polysaccharide chain length affects bacterial 
physiology and numerous cellular attributes, including cell perme-
ability, morphology, mechanical integrity, resistance to environ-
mental stress, periplasm size, and antibiotic susceptibility. Our 
findings highlight how bacteria can modulate polysaccharide length 
to respond to environmental stresses. The observation that strains 
of bacteria can modulate galactan chain length (7) highlights the 
flexibility endowed by the template-independent synthesis used to 
create glycans. This flexibility could be an advantage in responding 
to dynamic changes in the environment. Last, our data suggest that 
agents that block galactan biosynthesis could enhance susceptibility 
to known hydrophobic antibiotics.
MATERIALS AND METHODS
Bacterial strains and culture conditions
M. smegmatis mc2155 and derived mutants were grown with shaking 
at 37°C in Middlebrook 7H9 broth (BD, Franklin Lake, NJ) supple-
mented with 0.2% (w/v) glucose, 0.2% (v/v) glycerol, 0.5% (w/v) bovine 
serum albumin (United States Biological, Salem, MA), catalase 
(4 mg/liter) (Sigma-Aldrich), 15 mM sodium chloride, and 0.05% 
(v/v) Tween 80. Cells were maintained on agar plates using 7H10 
agar (BD, Franklin Lake, NJ) supplemented with 0.2% (v/v) glucose, 
0.2% (v/v) glycerol, 0.5% (w/v) bovine serum albumin (United 
States Biological, Salem, MA), catalase (4 mg/liter) (Sigma Aldrich), 
and 15 mM sodium chloride. When necessary, antibiotic selections 
were performed using kanamycin (20 g/ml), hygromycin B (50 g/ml), 
and gentamicin (2.5 g/ml).
Molecular biology methods and cloning
All cloning was performed using DH5 (NEB) grown in LB supple-
mented with kanamycin (50 g/ml) or ampicillin (100 g/ml) when 
appropriate. Plasmids and oligonucleotide primers used in this 
study are described in table S2. For protein expression and purification, 
M. smegmatis glfT2 was cloned into pET28a. Site-directed mutation 
constructs were amplified by polymerase chain reaction (PCR), 
phosphorylated by T4 Polynucleotide Kinase (NEB), ligated by 
Fermentas T4 DNA Ligase (Thermo Fisher Scientific), digested 
with Dpn-1 (NEB), and transformed into DH5. Correct constructs 
were identified by Sanger sequencing. For expression of constructs 
within M. smegmatis, glfT2 was cloned into pAMJ7, an integration- 
proficient vector. pAMJ7 was generated by replacement of the 
kanamycin resistance cassette in pTTP1B with a gentamicin resist-
ance cassette. The same primers used to develop point variants for 
pET vector plasmids were used to develop point variants of integration- 
proficient vectors.
Recombineering was used to replace glfT2 on the M. smegmatis 
chromosome with a hygromycin B resistance cassette. Briefly, a 
modified recombineering plasmid (pAMJ23) was created by intro-
duction of glfT2 into pJV48. The resultant plasmid was electro-
porated into WT M. smeg. The allelic exchange substrate (AES) was 
generated by creation of a plasmid (pAMJ36) containing a hygro-
mycin resistance cassette flanked by 500 base pairs (bp) on each side 
containing homology to the 5′ and 3′ ends of glfT2, respectively. 
The glfT2 deletion fragment was liberated from pAMJ36 by restriction 
digest with Afe I and Sbf I and purified by agarose gel extraction. 
M. smegmatis transformed with pAMJ23 were grown to mid-log in 
7H9 supplemented with glycerol and Tween 80 only. Once at mid-
log, induction of recombineering proteins was initiated by addition 
of acetamide to a final concentration of 0.2% (w/v). After a 3-hour 
induction, electrocompetent cells were made from this culture, and 
these cells were then electroporated with 200 ng of AES. Trans-
formed cells were recovered in complete 7H9 for 4 hours at 37°C 
and were then plated onto 7H10 plates supplemented with hygro-
mycin (50 g/ml). Colonies that grew were screened by PCR using 
primers described in table S2. PCR product that matched the pre-
dicted size for a glfT2 deletion strain (pAMJ36 M. smegmatis) was 
sequenced by Sanger sequencing. Legitimacy of this strain was vali-
dated by next-generation sequencing.
Integration-proficient vectors harboring glfT2 mutations were 
electroporated into pAMJ36 M. smegmatis. The original recombi-
neering plasmid, pAMJ23, was then removed by plating these cells 
on 7H10 plates supplemented with ADC (albumin-dextrose-catalase 
supplement) and 10% sucrose (w/v). Because pAMJ23 contains sacB, 
a negative selectable marker lethal in the presence of sucrose, only 
those cells that expel pAMJ23 will grow. However, cells lacking a 
functional copy of glfT2 will lose viability following expulsion of 
pAMJ23. To determine viability following exposure to sucrose, 
colony-forming units (CFU) were determined. In some cases, suppressor 
mutations can silence sacB lethality, preventing efficient removal of 
pAMJ23 from the cells. In such cases, cells retain kanamycin resist-
ance. Consequently, experiments that found high bacterial viability 
combined with kanamycin resistance following sucrose exposure were 
removed from analysis, as they were likely reflective of sacB sup-
pressor mutations, rather than efficient clearance of pAMJ23 from 
the cell. Expression of Flag-glfT2 constructs was validated using 
Western blotting with a FLAG-M2-HRP (horseradish peroxidase) 
conjugate antibody (diluted 1:1000, Sigma-Aldrich).
Protein expression and purification
A homology model for M. smeg GlfT2 was generated using SWISS- 
MODEL (35). Protein was expressed in DE3 Tuner cells. Starter cul-
tures were used to inoculate 1-liter cultures of LB supplemented 
with kanamycin to 50 g/ml. These cultures were grown to mid-log 
at 37°C, and once reaching OD600 (optical density at 600 nm) ~ 0.6, 
they were chilled on ice. Protein production was induced by addition of 
IPTG (isopropyl--D-thiogalactopyranoside) to 0.1 mM. Cultures 
were then incubated overnight at 16°C. Cells were then harvested 
by spinning at 4000 relative centrifugal force (RCF) for 10 min. Cell 
pellets were frozen at −80°C until purification.
Cell pellets were thawed on ice and resuspended in buffer A 
[50 mM sodium phosphate, 400 mM NaCl, 20 mM imidazole, 15% 
glycerol (pH 7.6)] supplemented with lysozyme (1 mg/ml), 1 mM 
phenylmethylsulfonyl fluoride (PMSF), 0.1% Triton X-100, and 
1250 U benzonase (Millipore Sigma). Cell lysis was completed by 
mechanical disruption at 22 kpsi (Constant Systems Cell Disruptor). 
The lysate was clarified by centrifugation at 20,000 RCF, and the 
supernatant was filtered using a 0.22-m PES EasyFlow syringe- drive 
filter (Millipore Sigma). GlfT2 constructs with N-terminal hexahistidine 
tags were purified using IMAC (immobilized metal affinity chroma-
tography). The filtered supernatant was loaded onto an ÄKTA fast 
protein liquid chromatography system and applied to a 1-ml 
HisTrap HP column (GE Healthcare). A linear, 5%/min gradient of 
buffer B [50 mM sodium phosphate, 400 mM NaCl, 400 mM 
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imidazole, 15% glycerol (pH 7.6)] was used to elute GlfT2 constructs. 
Fractions containing GlfT2 constructs were identified by SDS-PAGE, 
pooled, vitrified, and stored at −80°C.
GlfT2 in vitro assays
GlfT2 acceptor elongation experiments were set up similarly to pre-
vious reports (12). Kinetics parameters were determined using 
UDP-Glo (Promega). Enzyme acceptor binding was saturated by 
addition of acceptor to 200 M, and donor sugar (UDP-Galf) con-
centration varied from 15 to 1500 M with UDP-Galf. Kinetic reac-
tions were initiated by the addition of GlfT1 to 50 nM and quenched 
with UDP-Glo reagent after 40 min at room temperature. Reaction 
volumes were 10 l and were performed in quadruplicate. This time 
point was chosen to avoid any artifacts owing to quenching the re-
action during kinetic lag phase (36).
Cell length determination
Cells were grown in supplemented 7H9 medium and incubated 
with FM-464 (5 g/ml) to stain the cell membrane. Cells were 
placed on a 1.0% agarose pad. Images were collected using a Nikon 
Eclipse Ti-E epifluorescence microscope using a 100× objective. 
Length determination was determined using NIS-Elements software. 
Cell boundaries were determined using thresholding for bright ob-
jects, and of the cells selected, only single cells were measured. Sta-
tistical significance was determined by unpaired t test (P < 0.0001).
Transmission electron microscopy
Cells were grown to mid-log in supplemented 7H9 medium. Fixation, 
dehydration, embedding, sectioning, and microscopy were performed 
similar to as previously described (37). Periplasm size was determined 
using ImageJ. Distance between the inner and outer membranes 
was measured in at least 10 locations per cell, and the average of 
those individual measurements was taken as the periplasm size for 
that cell. For initial imaging using WT, WTcomp, and D267Ecomp strains, 
100 cells were analyzed for each strain. Statistical significance was 
determined by unpaired t test (P <0.0001). Subsequent imaging using 
WT, Cdiphcomp, Nbrascomp, and D267Ecomp strains analyzed 30, 30, 
25, and 23 cells, respectively.
Cryo-TEM
Cells were cultured to mid-log in complete 7H9 and concentrated 
50-fold by pelleting by centrifugation and resuspending in a 50-fold 
smaller volume. Concentrated cells were plunge-frozen in liquid 
ethane using an automated Leica EM GP system (Leica Microsystems) 
using R2/2 200 mesh grids (Quantifoil) and imaged using a Talos 
120 kV cryo-transmission electron microscope. For quantification, 
the distance between the inner and outer membranes was measured 
an average of 10 individual locations per cell. The mean of those 
individual measurements was taken as the periplasm size for that 
cell. Twenty-five cells were analyzed for each strain.
Time-lapse microscopy
Cells were grown to mid-log and diluted to OD600 of 0.1. Cells were 
loaded into a CellASIC (B04A) plate with constant fully supple-
mented 7H9 flow in a 37°C chamber. Images were taken every 
15 min on an inverted Nikon TI-E microscope using a 60× objective. 
Cells were imaged using phase contrast. For analyzing frequency of 
blebbing, cells were loaded into the B04A plate, and images from 
the initial time point were used to score for blebbing. Undistorted 
rod-shaped cells were counted as phenotypically normal, and cells 
with circular protrusions were counted as undergoing blebbing. 
Scoring was performed in technical quadruplicate.
Minimum inhibitory concentration determination
Antibiotic sensitivity was determined using an alamarBlue assay 
similar to previous reports (38). Briefly, cells were cultured to late-
log phase using supplemented 7H9 medium and diluted to 
OD600 = 0.05. An antibiotic of interest was then added and diluted 
serially twofold in a black 96-well plate (Corning). The final volume 
of cultures was 100 l. Cells were incubated with shaking for 24 hours 
at 37°C. Cell viability was determined by adding 6 l of alamarBlue 
(Thermo Fisher Scientific) in each well. The plate was then incubated 
at 37°C for 1 hour, and fluorescence (emission, 590 nm) was measured.
SDS sensitivity
Minimum inhibitory concentration (MIC) for SDS sensitivity was 
conducted similar to antibiotics. Viability of cells following expo-
sure to SDS was determined by culturing strains to mid-log, supple-
menting with SDS to 0.05% (w/v), and incubating for 4 hours at 
room temperature. CFU were then determined for each strain, with 
and without SDS added. Concentration of SDS was chosen based on 
previous hypersusceptibility phenotypes.
RNA sequencing
Cells were grown to mid-log in either supplemented 7H9 or supple-
mented 7H9 with 250 mM NaCl. Cells were harvested by centrifu-
gation at 3000 RCF for 10 min, and cell pellets were resuspended in 
TRIzol. Cell suspensions were frozen at −80°C. RNA extraction, 
library preparation, and sequencing were performed as previously 
described (39). Raw data analysis was performed similar to previous 
work (40). Statistical significance was determined by unpaired t test.
Mycolyl-arabinogalactan-peptidoglycan isolation
Cell envelope material was extracted similar to previous protocols. 
Isolation of mycolyl-arabinogalactan-peptidoglycan (mAGP) was 
conducted similar to previous reports (8,  41). Briefly, cell pellets 
were thawed on ice and resuspended in 50 ml of phosphate-buffered 
saline (PBS) supplemented with 2% Triton X-100. Cells were lysed 
at 22 kpsi with a benchtop cell disruptor from Constant Systems 
(Kennesaw, GA), and lysate was clarified by centrifugation (20,000 
RCF for 1 hour). The supernatant was discarded, and insoluble pellet 
was extracted three times with 2% SDS in PBS for 1 hour at 95°C. 
Following the third extraction, mAGP material was washed with 
milli-Q water, 80% acetone in water, and 100% acetone. Residual 
acetone was allowed to evaporate overnight.
Cell envelope composition analysis
Galactan length determination
Composition analysis was performed using 300 to 400 g of sample. 
A 10-g aliquot of inositol was added to the samples, which were 
then dried. Samples were hydrolyzed in 2 M trifluoroacetic acid 
(TFA) for 2 hours in a sealed tube at 121°C, reduced with NaBD4, 
and acetylated using acetic anhydride/TFA. Resulting alditol acetates 
were analyzed on an Agilent 7890A gas chromatograph (GC) inter-
faced to a 5975C MSD, electron impact ionization mode. Separation 
was performed on a 30-m Supelco SP-2331 bonded phase fused silica 
capillary column. Alongside the samples, a standard containing 1 g 
of rhamnose, 15 g of arabinose, 10 g of inositol, and 10 g of 
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galactose was run. The reported Ara:Gal:Rha ratios were an average 
of either three biological replicates (WT and D267Ecomp) or two bio-
logical replicates (WTcomp, Cdiphcomp, and Nbrascomp).
Quantification of MurNAc residues
Composition analysis was performed by combined GC/mass spec-
trometry (GC/MS) of heptafluorobutyric acid (HFBA) derivatives 
of monosaccharide methyl glycosides produced from acidic metha-
nolysis. Briefly, 700 to 900 g of mAGP were heated with 6 M HCl 
for 17 hours at 105°C. After heating, the sample was dried thoroughly 
by a stream of nitrogen and repeated additions of methanol. Metha-
nolysis was carried out by addition of methanolic HCl for 15 min at 
80°C. After cooling and removal of the solvent with nitrogen, the 
sample was treated with 200 l of acetonitrile and 50 l of the HFBA 
reagent. After reacting for 30 min at 105°C, the sample was dried 
and dissolved in acetonitrile. GC/MS analysis of the HFBA methyl 
glycosides was performed on an Agilent 7890A GC interfaced to a 
5975C MSD, using a Supelco DB-5 fused silica capillary column 
(30 m × 0.25 mm). For quantitation, 2-aminoadipic acid was used 
as an internal standard. To create a comparison of Rha/MurNAc 
residues, relative abundance of these monosaccharides was calcu-
lated as a percentage of total mAGP mass.
Biolog determination of osmosensitivity
Cells were cultured in 7H9 medium to mid-log phase. They were 
diluted to OD600 = 0.1, diluted approximately 15-fold further into 
7H9 broth supplemented with Dye G (Biolog). This mixture was then 
added to PM09 plates, with each well containing 100 l of inoculated 
culture. Three plates were used per strain as technical replicates. 
Plates were incubated at 30°C for 72 hours. Data were analyzed sub-
tracting background signal measured from uninoculated wells that 
acted as negative controls.
Lipid isolation and analysis
Cells were cultured (50 ml of complete 7H9) to mid-log and harvested, 
and cell pellets were frozen at −80°C until further use. Lipid extraction 
began with resuspension of each cell pellet in 3 ml of 2:1 methanol: 
chloroform. The initial extraction took place overnight at room 
temperature with agitation. Delipidated cells were pelleted by cen-
trifugation at 300 RCF, and the supernatant was carefully removed. 
Delipidation continued with addition of 3 ml of 1:2 methanol: 
chloroform. Extraction proceeded with agitation at 55°C for 2 hours. 
Delipidated cells were pelleted by centrifugation at 300 RCF, and 
the supernatant was carefully removed. This extraction was then 
repeated a second time, for a total of three extractions. Both the 
delipidated cells and supernatant were then evaporated overnight 
under nitrogen. After evaporation, the material from the superna-
tant fraction was subjected to a Folch wash. It was resuspended in 
4:2:1 chloroform:methanol:water, with water being supplemented 
with 0.9% NaCl (w/v). Following extraction, the two phases were 
separated and evaporated under nitrogen flow. The aqueous layer was 
carried forward for LM (lipomannan)/LAM (lipoarabinomannan) 
analysis, whereas the organic layer contained freely extractable lipids. 
These lipids were dissolved in 2:1 chloroform:methanol and were 
analyzed by thin-layer chromatography (TLC) using 20:4:0.5 
chloroform:methanol:water. The plate was developed by staining in 
10% cupric sulfate and charring. Assignments of lipids were per-
formed using Madacki et al. (42) as a reference.
Delipidated cells from the first series of extractions were then 
extracted for LM/LAM. Extractions used 3 ml of 50% ethanol at 85°C, 
and three extractions were performed in total. The first lasted for 3 hours, 
the second lasted for 2 hours, and the third lasted for 1 hour. Between 
washes, insoluble material was pelleted by centrifugation at 300 RCF. 
The 9 ml of 50% ethanol was combined with the aqueous layer of the 
Folch wash. These combined fractions were then evaporated under 
nitrogen. The dried material was redissolved in 2 ml of water and 
extracted three times with 2 ml of PBS-saturated phenol at 80°C. The 
samples were then dialyzed, separated via SDS-PAGE, and stained 
with the Pro-Q Emerald stain (Thermo Fisher Scientific). Assignment 
of bands was determined using Jankute et al. (43) as a reference.
Last, mycolic acids covalently appended to the mAGP were ana-
lyzed. Insoluble delipidated cells were resuspended in 1 ml of 15% (w/v) 
tetrabutylammonium hydroxide. To release free mycolic acids, these 
suspensions were heated at 98°C overnight. Permethylation was per-
formed by addition of dichloromethane (DCM) (1.5 ml), milli-Q 
filtered H2O (1.0 ml), and iodomethane (150 l). This reaction pro-
ceeded for 4 hours at room temperature, yielding mycolic acid methyl 
esters (MAMEs). After two washes with water (2 ml each), the organic 
phase was evaporated under nitrogen. Diethyl ether (2.0 mL) was added 
to each sample to extract MAMEs and after evaporation under nitro-
gen, MAMEs were resuspended in DCM (100 l) and analyzed via 
TLC using 95:5 hexanes:ethyl acetate as the mobile phase. Plate was 
developed by staining in 10% cupric sulfate and charring. Assignments 
of lipids were performed using Madacki et al. (42) as a reference.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/38/eaba4015/DC1
View/request a protocol for this paper from Bio-protocol.
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